Both in Pharmaceuticals
TG Therapeutics vs Arrowhead Research
Over the past year TGTX returned +82.3% and ARWR returned +62.9%; their daily moves had a correlation of 0.24.
TGTX +82.3% ARWR +62.9%Growth of $1, one year, split-adjusted
| Metric | TGTX | ARWR |
|---|---|---|
| Price | $61.63 | $61.65 |
| Market cap | $9.43B | $8.71B |
| Today | +1.45% | +3.56% |
| 1 month | +18.1% | +0.2% |
| 6 months | +46.8% | −22.1% |
| Year to date | +106.7% | −7.1% |
| 1 year | +82.9% | +55.6% |
| Revenue growth (YoY) | +70.3% | +171.0% |
| Gross margin | 82.9% | 100.0% |
| Net margin | 3.2% | −258.2% |
| P/E (TTM) | 21.4× | — |
| Price / sales | 11.8× | 13.0× |
| Net cash | -$193.1M | $737.9M |
| Dividend yield | — | — |
| Volatility (60d) | 36.8% | 45.8% |
| Short % of float | 20.1% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).